Increasing awareness of autoimmune diseases is creating demand for advanced immunological testing methods. ELISA-based assays help healthcare professionals evaluate specific antibodies associated with different autoimmune conditions.
Market Overview
The Enzyme-Linked Immunosorbent Assay (ELISA) Market was valued at US$ 2.47 billion in 2025 and is projected to reach US$ 4.13 billion by 2034,...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)